Journal Article

Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B

Surdo, Matteo, Salpini, Romina, Piermatteo, Lorenzo, Battisti, Arianna, Hansi, Navjyot, Perno, Carlo Federico, Colagrossi, Luna, Ceccherini Silberstein, Francesca, Gill, Upkar S, Kennedy, Patrick T F, Nuccitelli, Andrea, Cacciafesta, Valeria, Scutari, Rossana, Carioti, Luca, Svicher, Valentina

2021

Overview

ObjectiveThe involvement of HBV DNA integration in promoting hepatocarcinogenesis and the extent to which the intrahepatic HBV reservoir modulates liver disease progression remains poorly understood. We examined the intrahepatic HBV reservoir, the occurrence of HBV DNA integration and its impact on the hepatocyte transcriptome in hepatitis B ‘e’ antigen (HBeAg)-negative chronic hepatitis B (CHB).DesignLiver tissue from 84 HBeAg-negative patients with CHB with low (n=12), moderate (n=25) and high (n=47) serum HBV DNA was analysed. Covalently closed circular DNA (cccDNA), pregenomic RNA (pgRNA) were evaluated by quantitative PCR, whole exome and transcriptome sequencing was performed by Illumina, and the burden of HBV DNA integrations was evaluated by digital droplet PCR.ResultsPatients with low and moderate serum HBV DNA displayed comparable intrahepatic cccDNA and pgRNA, significantly lower than in patients with high HBV DNA, while hepatitis B core-related antigen correlated strongly with the intrahepatic HBV reservoir, reflecting cccDNA quantity. Whole exome integration was detected in a significant number of patients (55.6%, 14.3% and 25% in high, moderate and low viraemic patients, respectively), at a frequency ranging from 0.5 to 157 integrations/1000 hepatocytes. Hepatitis B surface antigen >5000 IU/mL predicted integration within the exome and these integrations localised in genes involved in hepatocarcinogenesis, regulation of lipid/drug metabolism and antiviral/inflammatory responses. Transcript levels of specific genes, including the proto-oncogene hRAS, were higher in patients with HBV DNA integration, supporting an underlying oncogenic risk in patients with low-level to moderate-level viraemia.ConclusionsHBV DNA integration occurs across all HBeAg-negative patients with CHB, including those with a limited HBV reservoir; localising in genes involved in carcinogenesis and altering the hepatocyte transcriptome.

• Publisher: BMJ Publishing Group Ltd and British Society of Gastroenterology,BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Adult / Antigens / Antiviral drugs / Biomarkers - blood / Biopsy / Carcinogenesis / Cell cycle / chronic viral hepatitis / Circular DNA / Circular RNA / DNA sequencing / DNA, Viral - blood / DNA, Viral - genetics / Drug metabolism / Exome Sequencing / Female / Gene expression / Gene regulation / Genomes / Genotype / Hepatitis B / Hepatitis B e antigen / Hepatitis B e Antigens - blood / Hepatitis B surface antigen / Hepatitis B virus - genetics / Hepatitis B, Chronic - genetics / hepatocellular carcinoma / Hepatocytes / Hepatocytes - virology / Hepatology / High-Throughput Nucleotide Sequencing / Humans / Infections / Inflammation / Integration / Interferon / Lipid metabolism / liver biopsy / Liver cancer / Liver diseases / Localization / Male / Metabolism / Middle Aged / Patients / Polymerase chain reaction / Transcription / Transcriptome / Transcriptomes / Viremia